Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-09-24Clinical Trial Update: A Dose Escalation Study of SHP2 Inhibitor in Patients With Solid Tumors Harboring KRAS of EGFR Mutations [Phase 1]
A Phase 1 dose-escalation trial of an SHP2 inhibitor in patients with solid tumors harboring KRAS or EGFR mutations is currently active and …
-
CLINICAL_TRIALS research · 2025-09-24Clinical Trial Update: Impact of Dysbiosis-inducing Drugs on Effectivity of Immune Checkpoint Inhibitor in Non-small Cell Lung Cancer Patients
A clinical trial update describes a study investigating whether dysbiosis-inducing drugs influence the effectiveness of an immune checkpoint…
-
CLINICAL_TRIALS research · 2025-09-23Clinical Trial Update: Peptide Vaccine To Prevent Acquired Resistance In Patients With Advanced ALK+ NSCLC [Phase 1, Phase 2]
A Phase 1/2 clinical trial is evaluating a peptide vaccine to prevent acquired resistance in patients with advanced ALK-positive non-small c…
-
CLINICAL_TRIALS research · 2025-09-23Clinical Trial Update: The Role of DNA and RNA in NGS Analyses for Advaced Stage NSCLC Patients [NA]
The trial investigates the role of DNA and RNA sequencing in NGS analyses for advanced-stage non-small cell lung cancer. Recruitment is curr…
-
CLINICAL_TRIALS research · 2025-09-22Clinical Trial Update: A Study of HLX42 in Advanced/Metastatic Solid Tumors [Phase 1]
Phase 1 clinical trial evaluating HLX42 in advanced/metastatic solid tumors, including non-small cell lung cancer, is currently recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-09-19Clinical Trial Update: High-Dose Firmonertinib Plus Bevacizumab as Neoadjuvant Therapy for Resectable EGFRm Stage II-IIIB NSCLC [Phase 2]
A Phase 2 neoadjuvant trial evaluating high-dose firmonertinib in combination with bevacizumab for resectable EGFR-mutant stage II-IIIB non-…
-
CLINICAL_TRIALS research · 2025-09-19Clinical Trial Update: Clinical Effectiveness Assessment of VeriStrat® Testing and Validation of Immunotherapy Tests in NSCLC Subjects
This Clinical Trial Update reports on the ongoing assessment of the clinical effectiveness of VeriStrat biomarker testing and the validation…
-
CLINICAL_TRIALS research · 2025-09-19Clinical Trial Update: JYP0322 Versus Platinum Based Doublet Chemotherapy in ROS1 Positive Patients Previously Treated With ROS1-TKIs. [Phase 3]
A Phase 3 clinical trial comparison is planned between JYP0322 and platinum-based doublet chemotherapy in ROS1-positive non-small cell lung …
-
CLINICAL_TRIALS research · 2025-09-19Clinical Trial Update: The Use of Molecular Radiogenomics in Non-small Cell Lung Cancer
A clinical trial investigating molecular radiogenomics in non-small cell lung cancer is currently recruiting at Buddhist Tzu Chi General Hos…
-
CLINICAL_TRIALS research · 2025-09-19Clinical Trial Update: A Study of BL-B01D1 and BL-B01D1 in Combination With Osimertinib Mesylate Tablets in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer [Phase 2]
Phase 2 clinical trial evaluating BL-B01D1 in combination with osimertinib for locally advanced or metastatic non-small cell lung cancer is …
-
CLINICAL_TRIALS research · 2025-09-19Clinical Trial Update: BI-1910 as a Single Agent and in Combination With Pembrolizumab for the Treatment of Advanced Solid Tumors [Phase 1, Phase 2]
Clinical trial update for BI-1910 as a single agent and in combination with pembrolizumab in advanced solid tumors, including non-small cell…
-
CLINICAL_TRIALS research · 2025-09-19Clinical Trial Update: Nodify XL2 Classifier Clinical Utility Study in Low to Moderate Risk Lung Nodules
A clinical trial update indicates the Nodify XL2 classifier utility study for evaluating low to moderate risk lung nodules is currently acti…
-
CLINICAL_TRIALS research · 2025-09-18Clinical Trial Update: LIquid Biopsy to prEdict Responses To First-line immunotherapY in Metastatic Non-small Cell LUNG Cancer. LIBERTY LUNG [NA]
Clinical trial update describing a study investigating whether liquid biopsy can predict responses to first-line immunotherapy in metastatic…
-
CLINICAL_TRIALS research · 2025-09-18Clinical Trial Update: SUNSET: SBRT for Ultra-central NSCLC- a Safety and Efficacy Trial [Phase 1]
This entry describes an ongoing Phase 1 trial (SUNSET) evaluating SBRT for ultra-central non-small cell lung cancer, with status active but …
-
CLINICAL_TRIALS research · 2025-09-18Clinical Trial Update: Assessing the Efficacy and Safety of Selective Metabolically Adaptive Radiation Dose Escalation in Locally Advanced Non-Small Cell Lung Cancer Receiving Definitive Chemoradiotherapy [NA]
A clinical trial evaluating a selective metabolically adaptive radiation dose escalation approach in locally advanced non-small cell lung ca…
-
CLINICAL_TRIALS research · 2025-09-18Clinical Trial Update: AOH1996 for the Treatment of Refractory Solid Tumors [Phase 1]
AOH1996 is being studied in a Phase 1 trial for patients with refractory solid tumors, including osteosarcoma and several other sarcomas and…
-
CLINICAL_TRIALS research · 2025-09-18Clinical Trial Update: Assessment of Precision Irradiation in Early NSCLC and Interstitial Lung Disease [NA]
A clinical trial update indicates that NCT03485378, investigating precision irradiation for early non-small cell lung cancer and interstitia…
-
CLINICAL_TRIALS research · 2025-09-17Clinical Trial Update: Study of FIH of STX-241 in Locally Advanced or Metastatic NSCLC Resistant to EGFR TKIs [Phase 1, Phase 2]
Ongoing Phase 1/2 study of STX-241 in locally advanced or metastatic non-small cell lung cancer resistant to EGFR inhibitors. The trial is c…
-
CLINICAL_TRIALS research · 2025-09-17Clinical Trial Update: Analysis of Deoxyribonucleic Acid and Ribonucleic Acid Next-Generation Sequencing in Non-Small Cell Lung Cancer Patients Without Pathological Complete Response Following Neoadjuvant Immunotherapy
This clinical trial analyzes DNA and RNA next-generation sequencing in non-small cell lung cancer patients who did not achieve pathological …
-
CLINICAL_TRIALS research · 2025-09-17Clinical Trial Update: PEmbRolizumab verSus chEmotherapy and pEmbrolizumab in Non-small-cell Lung Cancers (NSCLC) With PDL1 ≥ 50 % [Phase 3]
Phase 3 trial update evaluating pembrolizumab with or without chemotherapy in PD-L1–high non-small cell lung cancer, currently listed as act…
-
CLINICAL_TRIALS research · 2025-09-17Clinical Trial Update: A Study of HS-10504 in Patients With Advanced or Metastatic Non-Small-Cell Lung Cancer(NSCLC) [Phase 1]
This clinical trial update reports that HS-10504 is being studied in a Phase 1 trial for patients with locally advanced or metastatic non-sm…
-
CLINICAL_TRIALS research · 2025-09-17Clinical Trial Update: Clinical Benefit and Biomarker Analysis of Combination of PD-1/PD-L1 Immune Checkpoint Inhibitors and Radiotherapy
A clinical trial is evaluating the combination of PD-1/PD-L1 immune checkpoint inhibitors with radiotherapy across several cancers to assess…
-
CLINICAL_TRIALS research · 2025-09-17Clinical Trial Update: A Study of MGC028 in Participants With Advanced Solid Tumors [Phase 1]
Clinical trial update for MGC028 in participants with advanced solid tumors. This Phase 1 study is currently recruiting to evaluate safety a…
-
CLINICAL_TRIALS research · 2025-09-16Clinical Trial Update: Brigatinib and Bevacizumab for the Treatment of ALK-Rearranged Locally Advanced, Metastatic, or Recurrent NSCLC [Phase 1]
Phase 1 clinical trial update for Brigatinib plus Bevacizumab in ALK-rearranged non-small cell lung cancer (locally advanced to metastatic/r…
-
CLINICAL_TRIALS research · 2025-09-16Clinical Trial Update: ALG-LungCancerRegistry (SAFRO2202)
An ongoing clinical trial registry in Algeria (SAFRO2202) for lung cancer is recruiting patients with non-small cell lung cancer, small cell…